MedMountain Ventures

Confido Health specializes in AI-driven solutions that enhance healthcare operations by automating tasks such as appointment management and patient follow-ups. The company's platform is designed to facilitate communication between healthcare staff, patients, and wellness coaches, effectively reducing administrative burdens. By integrating with existing systems, Confido Health enables healthcare providers to streamline processes and focus more on delivering quality patient care. Its technology aims to improve operational efficiency within surgery centers and other healthcare facilities.

AvoMD operates a no-code software platform that enhances the accessibility of clinical content, such as guidelines, algorithms, pathways, and checklists, by transforming it into "virtual clinical consults." This content is available instantly at the point-of-care through standalone web and mobile applications, as well as integration within electronic health records (EHR). By partnering with leading health systems and medical societies, AvoMD aims to deliver immediate expert guidance to clinicians at the bedside. Research indicates that the platform not only improves patient outcomes but also significantly reduces the time clinicians spend accessing vital information, leading to increased efficiency in healthcare delivery.

Gradient Health is a developer of an open research platform focused on providing AI-based medical imaging diagnostics and infrastructure. The platform offers comprehensive access to a clinical sandbox, along with open-source tools and documentation that are readily available to developers. This framework facilitates the translation of research into a secure and interoperable clinical environment, enhancing the capabilities and efficiency of medical imaging diagnostics.

Eddii is a health tracking application aimed at individuals living with diabetes, designed to enhance engagement and motivation in managing their health. The application features a virtual character that encourages users to record their daily wellness and adhere to healthy routines through gamification. By providing witty conversations and helpful tips, Eddii aims to make the process of tracking health enjoyable. Users receive weekly reports that highlight their progress, and the app rewards healthy practices and achievements with in-app incentives, fostering a supportive environment for better diabetes management.

Epitel is a digital health company focused on developing a wearable, wireless EEG monitoring platform aimed at improving seizure detection. The company offers a brain health monitoring device that accurately identifies abnormal brain activities using a proprietary cloud-based wearable sensor system combined with advanced artificial intelligence technologies. This innovative approach provides accessible, affordable, and reliable electrographic seizure detection, allowing physicians, caregivers, and patients with neurological disorders to gain valuable insights into brain health. By enhancing the quality of life and care for individuals affected by these conditions, Epitel strives to make significant contributions to the field of digital health.

Options MD is a telemedicine platform focused on delivering personalized care for individuals experiencing severe and treatment-resistant mental illnesses. The platform utilizes artificial intelligence to match patients with innovative depression care options provided by psychiatric experts. By streamlining the referral process to in-house specialists, Options MD enables patients to access appropriate medical care more efficiently, aiming to improve their treatment outcomes.

Options MD is a telemedicine platform focused on delivering personalized care for individuals experiencing severe and treatment-resistant mental illnesses. The platform utilizes artificial intelligence to match patients with innovative depression care options provided by psychiatric experts. By streamlining the referral process to in-house specialists, Options MD enables patients to access appropriate medical care more efficiently, aiming to improve their treatment outcomes.

Inherent Biosciences is a molecular diagnostics company focused on transforming the trial and error approach in medicine by leveraging insights from epigenetics. The company aims to provide clarity on complex health issues by identifying dysregulation across multiple genes and pathways, which informs personalized treatment strategies. Inherent Biosciences develops innovative therapies for a range of conditions, including pain, infertility, embryo quality, autism, rheumatoid arthritis, psoriatic arthritis, fetal heart disease, and COVID-19. By translating biological discoveries into actionable insights, the company seeks to enhance patient care and improve outcomes in various medical fields.